cytotoxicity. Furthermore, disabling this protective mechanism significantly sensitizes CLL cells to drug treatment in the stromal environment. This stromal-leukaemia interaction is critical for CLL cell survival and represents a key biochemical pathway for effectively targeting leukaemia cells to overcome drug resistance in vivo.
chemotherapy often leads to disease relapse. Thus, it is important to understand the mechanisms by which stromal cells protect leukaemia cells to develop effective therapeutic strategies to eliminate leukaemia cells in vivo.
Recent technological developments have allowed global analyses of biochemical alterations in cancer, and enabled the discovery of potential roles of metabolites such as sarcosine and 2-hydroxyglutarate in cancer development [17] [18] [19] . Among the small molecules involved in cell survival and drug resistance, GSH is particularly important for CLL cells owing to the unique biological properties of this leukaemia. CLL cells intrinsically have higher levels of reactive oxygen species (ROS) when compared with normal lymphocytes [20] [21] [22] , and are highly sensitive to agents that induce further ROS stress 20, 23 . The elevated ROS level renders CLL cells more dependent on cellular antioxidants such as GSH to maintain the redox balance. However, CLL cells are unable to maintain GSH once they are isolated from patients and cultured in vitro, exhibiting a high level of spontaneous apoptosis 6, 24 . Here we show that the bone marrow stromal cells promote GSH metabolism in CLL cells and enhance the leukaemia cell survival and drug resistance. We also identified a potential therapeutic strategy to overcome this stromal protection of CLL cells by abrogating the GSH system. 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 10 4 10 0 10 1 10 2 10 3 
RESULTS

Bone marrow stromal cells promoted GSH synthesis in CLL cells and relieved their ROS stress
Previous studies indicate that CLL cells have intrinsic ROS stress 20, 25 and exhibit a high level of spontaneous apoptosis with a loss of GSH when cultured in vitro, but have a prolonged survival time in vivo 6, 24 . To investigate the interaction of bone marrow stromal cells and CLL cells, we employed a co-culture system using several bone marrow stromal cell lines and primary leukaemia cells isolated from CLL patients. As shown in Fig. 1a , CLL cells cultured alone exhibited substantial spontaneous cell death within 3 days, whereas bone marrow stromal cells (HS5) significantly enhanced CLL cell viability. Similar protection was also observed in a long-term (3 weeks) co-culture ( Supplementary  Fig. S1A ). The ability of stromal cells to enhance CLL cell viability was consistently observed when the cells were cultured under ambient oxygen (21% O 2 ) or reduced oxygen (2-5%) that resembles the in vivo oxygen conditions in 4 CLL samples tested ( Supplementary  Fig. S1B ,C), indicating that this protective effect was the consequence of stromal-CLL cell interaction, not due to the artificial effect of the oxygen environment. When cellular GSH was measured, we observed a pronounced difference in CLL cells cultured with or without stromal cells. CLL cells cultured alone showed a time-dependent decrease in GSH, whereas GSH was maintained at high levels when co-cultured with HS5 stromal cells ( Fig. 1b ). Comparison of 35 CLL samples cultured for 3 days with or without stromal cells showed that the level of GSH was significantly higher in CLL cells co-cultured with the bone marrow stromal cells ( Fig. 1c ). Thirty-three of the 35 CLL samples exhibited a more than 100% increase in co-culture, with GSH in the range of 1.5-4 nmol per 10 7 cells in most of the samples, whereas most CLL cells cultured alone had less than 0.5 nmol per 10 7 cells on day 3 ( Supplementary Fig. S2 ).
We then investigated whether the bone marrow stromal cells could relieve the intrinsic oxidative stress in CLL cells by enhancing the level of GSH. Figure 1d shows that CLL cells co-cultured with HS5 cells had lower ROS and higher cellular thiol (mainly GSH) levels. Moreover, this redox change rendered CLL cells more resistant to exogenous ROS stress by H 2 O 2 (Fig. 1e ). We also evaluated two other bone marrow stromal cell lines (StromaNKtert and KUSA-H1; ref. 26) for their effect on GSH in CLL cells, and showed that these stromal cells consistently enhanced GSH in all 6 CLL patient samples tested ( Fig. 1f ), leading to a decrease in ROS ( Fig. 1g ).
Critical role of GSH in mediating stromal protection of CLL cells
The role of GSH in mediating stromal protection of CLL cells was then investigated in the co-culture system with or without drug treatment. As shown in Fig. 2a and Supplementary Fig. S3A , HS5 stromal cells significantly reduced the level of CLL cell death that occurred either spontaneously or induced by F-ara-A (active form of fludarabine) or oxaliplatin, two drugs used in the clinical treatment of CLL. Two other bone marrow stromal lines (StromaNKtert and KUSA-H1) also exhibited a similar protective effect ( Supplementary  Fig. S3B ). The addition of N -acetylcysteine (NAC, a GSH precursor) or glutathione to the medium enhanced CLL cell viability without stromal cells (Fig. 2b,c) , indicating that increasing the GSH level by chemical supplementation was sufficient to promote cell survival. These data also indicate that CLL cells were able to use exogenous GSH for glutathione synthesis, consistent with the report that γ-glutamyl transpeptidase and dipeptidase on the cell surface can cleave GSH to provide cysteine for GSH synthesis 27 . Indeed, exogenous GSH enhanced GSH in CLL cells in a concentration-dependent manner ( Fig. 2c, right panel) .
Furthermore, the stromal protection of CLL cells could be abrogated by depletion of GSH using β-phenylethyl isothiocyanate (PEITC), a natural compound capable of rapidly depleting cellular glutathione 23, 28 . As shown in Fig. 2d , 5 µM PEITC significantly decreased the level of GSH in CLL cells co-cultured with stromal cells. Depletion of GSH by PEITC was toxic to CLL cells and enhanced the cytotoxic effect of F-ara-A or oxaliplatin in the presence of stromal cells ( Fig. 2e ). This was observed in multiple leukaemia samples from 10-30 CLL patients ( Fig. 2e, right panel) .
The low-molecular-weight fraction of the stromal medium enhanced GSH synthesis in CLL cells and promoted cell survival
Using a Transwell co-culture system with a membrane to prevent direct contact between stromal and CLL cells, we showed that HS5 cells conferred a significant protection to CLL cells treated with F-ara-A, oxaliplatin or H 2 O 2 (Fig. 3a ). Similar protection was consistently observed using two other stromal lines (StromaNKtert and KUSA-H1; Supplementary Fig. S3B ), indicating that stromal protection was probably mediated by a diffusible factor. This was further confirmed by using stromal-conditioned medium to enhance GSH synthesis in CLL cells ( Fig. 3b ) and promote CLL cell survival without stromal cells (Fig. 3c ). The expression of γ-glutamylcysteine liganse (GCLC), a rate-limiting enzyme in GSH synthesis 29 , was not enhanced by stromal co-culture in 16 CLL samples tested ( Supplementary Fig. S4 ), indicating that the soluble factor that promoted GSH synthesis in CLL cells did not upregulate this rate-limiting enzyme.
When the stromal-conditioned medium was separated into highmolecular-weight (HMW) and low-molecular-weight (LMW) fractions using a relative molecular mass cutoff of 3,000 (M r 3K), we found that it was the LMW fraction that protected CLL cells against drug-induced cytotoxicity, whereas the HMW fraction showed little protection ( Fig. 3d ). Furthermore, incubation of CLL cells with the LMW fraction led to an increase in the level of GSH, similar to the GSH content in CLL cells cultured with unfiltered conditioned medium ( Fig. 3e ). Thus, a LMW component of less than M r 3K might play a key role in mediating the protective effect. Surprisingly, quantitative analysis showed no detectable increase in the level of GSH in the stromal medium, whereas the cellular GSH level in CLL cells increased significantly in co-culture ( Fig. 3f ). Using Ellman's reagent to detect total thiols, we found a significant increase in the level of thiols in the co-culture medium (Fig. 3g ). These data together indicate that the stromal cells might release a thiol-containing compound into the medium, but this compound was not GSH.
Conversion of cystine to cysteine by bone marrow stromal cells was essential to enhance GSH synthesis in CLL cells and promote their survival
As cysteine is a thiol-containing compound and a rate-limiting substrate for GSH synthesis 29 , we speculated that the LMW component in the stromal medium might be cysteine. Using liquid-chromatography /tandem mass spectrometry (LC-MS/MS) analysis, we indeed detected 10-50 µM of cysteine in the conditioned medium from 3 stromal cell lines, whereas the control medium contained little cysteine (0.12 µM; Fig. 4a ). The LC-MS/MS spectra of authentic cysteine in comparison with the cysteine in stromal medium are shown in Supplementary Fig. S5 . As human plasma contains 10-20 µM cysteine 30, 31 , we investigated whether these concentrations of cysteine could protect CLL cells without stromal co-culture. Daily addition of cysteine promoted CLL viability and suppressed druginduced cell death in a concentration-dependent manner (Fig. 4b ), and 50 µM cysteine enhanced GSH in CLL cells to the same level observed in stromal co-culture ( Fig. 4c ). Moreover, chemical conversion of the cystine in RPMI medium to cysteine by a reducing agent 2mercaptoethanol (2-ME, 20 µM) effectively increased the GSH level in CLL cells ( Fig. 4d ), confirming the importance of cysteine. Consistently, CLL cells lost their viability in regular medium (containing cystine) without 2-ME, whereas the addition of 2-ME conferred significant protection and kept most CLL cells viable (Fig. 4e ). In a separate experiment, 2-ME failed to protect CLL cells when cystine was omitted from the medium (Fig. 4f ), indicating that cystine was required to generate cysteine by 2-ME to provide the protective effect.
Leukaemia cells exhibited a low ability to directly use cystine and were dependent on stromal cells to convert cystine to cysteine for GSH synthesis
Cysteine is chemically unstable, and cells normally use the stable cystine as a precursor for GSH synthesis. We examined the expression of the cystine transporter Xc-, and found that xCT (the active subunit of Xc-) expression was very low in CLL cells. In contrast, xCT was highly expressed in bone marrow stromal cells ( Fig. 5a ). Using the National Center for Biotechnology Information gene expression omnibus database (ID: GDS1454) that contains microarray data from CLL and normal control samples 32 , we also found that the level of xCT messenger RNA expression in CLL cells (n = 100) was significantly lower than in normal lymphocytes (n = 11;P < 0.001). These data together indicate that CLL cells might have a limited ability to take up cystine owing to the low expression level of its transporter. We then carried out functional analysis and found that CLL cells exhibited very little uptake of [ 14 C]cystine, whereas HS5 stromal cells showed a significantly higher uptake ( Fig. 5b ). When [ 14 C]cystine was chemically converted to [ 14 C]cysteine by 2-ME, CLL cells could then take up a substantial amount of the radioactive substrate ( Fig. 5c ), indicating that CLL cells were able to transport cysteine but not cystine. There was a significant increase in the uptake of radioactivity by CLL cells when co-cultured with HS5 cells (Fig. 5d ), indicating that the stromal cells converted cystine to cysteine for uptake by CLL cells. Consistently, removal of cystine from the medium abrogated the ability of stromal cells to promote GSH synthesis in CLL cells (Fig. 5e ). We also found that stromal cells did not increase the level of expression of xCT in CLL cells ( Supplementary Fig. S4 ). These data together indicate that bone marrow stromal cells promoted GSH synthesis in CLL cells mainly by converting cystine to cysteine, not by enhancing the expression of the cystine transporter.
Overcoming drug resistance in the stromal environment by abolishing the GSH protective mechanism in vitro and in vivo
As enhancement of GSH synthesis in CLL cells is probably a key mechanism by which stromal cells promote leukaemia cell survival and drug resistance, we reasoned that abrogation of this protective mechanism would sensitize leukaemia cells to drug treatment in the stromal environment. Indeed, we found that PEITC, a compound known to cause rapid depletion of GSH in CLL cells 23 , was able to effectively abrogate the ability of HS5 stromal cells to protect CLL cells ( Fig. 2e ). This was consistently observed in experiments using two other bone marrow stromal cell lines (StromaNKtert and KUSA-H1; Fig. 6a ). Of note, combination of 10 µM PEITC and 20 µM oxaliplatin revealed a pronounced synergistic effect against CLL cells in the presence of stromal cells ( Supplementary  Fig. S6A ). The loss of p53 in CLL cells due to chromosome 17p deletion is known to cause drug resistance and poor prognosis 33, 34 . We found that combination of PEITC and oxaliplatin was highly effective in killing the CLL cells with 17p deletion in the presence of stromal cells (Fig. 6b ).
We then investigated another strategy to abolish stromal protection of CLL cells by inhibiting the cystine transporter to block the uptake of cystine by stromal cells. Two Xc-inhibitors, (S)-4carboxyphenylglycine (S-4-CPG; ref. 35 ) and sulphasalazine (SSZ; ref. 36) , were used in this study. As shown in Fig. 6c ,d, HS5 cells reduced the sensitivity of CLL cells to F-ara-A or oxaliplatin, and a subtoxic concentration of S-4-CPG (500 µM) and SSZ (300 µM) enhanced F-ara-A-or oxaliplatin-induced cytotoxicity to a level comparable to that observed in CLL cells without stromal protection. Similar results were also observed in experiments using a different CLL sample and another bone marrow stromal cell line (KUSA-H1; Supplementary  Fig. S6B ). In control experiments, we found that 300 µM SSZ and 500 µM S-4-CPG caused minimum cytotoxicity in normal bone marrow stromal cells, with 90-95% viable cells after the drug incubation ( Supplementary Fig. S6C ). The concentrations of F-ara-A (20 µM), oxaliplatin (20 µM) and PEITC (5-10 µM) used in these experiments are clinically relevant and consistent with other reports 23,37-39 .
The Tcl-1 transgenic mice, a mouse model that resembles human CLL disease 40 , were used to further evaluate the in vivo relevance of stromal-leukaemia interaction in cystine/GSH metabolism. As shown in Fig. 7a , blocking cystine uptake by in vivo administration of SSZ resulted in a significant decrease in the level of GSH in CLL cells (P < 0.001) in all 3 mice tested. In contrast, incubation of primary CLL cells with SSZ in vitro without stromal cells did not cause a significant change in cellular GSH (Fig. 7b ). These data together indicate that the higher concentration of GSH in CLL cells in vivo was due to stromal cell uptake of cystine and its conversion to cysteine for CLL cells. This metabolic communication was blocked by SSZ in vivo. Importantly, treatment of the mice with SSZ caused a significant reduction in leukaemia burden in all 4 mice tested. The number of leukaemia cells in the peritoneal cavity was reduced from 32.5 million to 11.4 million cells during a week of treatment (P = 0.0081; Fig. 7c ). CLL cells isolated from a mouse treated with SSZ showed a moderate decrease in cells viability (78% viable), compared with the CLL cells isolated from the same mouse before SSZ treatment (97% viable cells; Fig. 7d ). In vivo SSZ treatment rendered the leukaemia cells more sensitive to F-ara-A or oxaliplatin when cultured ex vivo, and this sensitization was partially reversed by co-culture with bone marrow stromal cells (Fig. 7d) . These data together indicate that inhibition of cystine transporter by SSZ in vivo could significantly reduce tumour burden, decrease leukaemia cell viability and increase their drug sensitivity. 
DISCUSSION
Our study revealed an important metabolic interaction between CLL cells and bone marrow stromal cells to enhance GSH synthesis, and thus increase the ability of CLL cells to maintain the redox balance and promote cell survival and drug resistance. As illustrated in Supplementary Fig. S7 , this metabolic pathway involves the uptake of cystine by stromal cells, the conversion of cystine to cysteine and its release to the microenvironment, and the uptake of cysteine by CLL cells for GSH synthesis. Several important factors underscore the critical need of this biochemical pathway to protect CLL cells. The intrinsic ROS stress in CLL cells renders them highly dependent on GSH to maintain the redox balance 23 , but they have a limited ability to take up cystine for GSH synthesis owing to the low expression level of cystine transporter Xc-. Although CLL cells can transport cysteine, this compound is chemically unstable in the extracellular environment and thus requires the constant production by stromal cells. Bone marrow stromal cells have a high expression level of Xc-and thus can effectively take up cystine and convert it to cysteine for use by CLL cells.
Accumulation of CLL cells in patients is due in part to a prolonged CLL cell survival in vivo 41 . Paradoxically, CLL cells often exhibit spontaneous apoptosis in vitro when cultured alone 42 . Thus, the in vivo environment has a profound effect on CLL cell survival. Although several stromal factors and cytokines have been implicated in promoting CLL cell viability [8] [9] [10] [11] [12] [13] [14] [15] [16] , the exact mechanisms by which the stromal environment protects CLL cells still remain unclear. Our study revealed an important intercellular metabolic pathway between CLL and bone marrow stromal cells that promoted CLL cell viability and drug resistance by enhancing GSH synthesis. Cysteine is a rate-limiting substrate for GSH synthesis. In many cell types, the main source of cysteine is the uptake of extracellular cystine and cysteine by their respective transporters [43] [44] [45] . Cysteine is transported by both Na + -dependent ASC and Na + -independent transporters 46 , whereas cystine is mainly transported by Xc-and converted to cysteine inside the cells 35, [47] [48] [49] . The plasma cystine level is in the 100-200 µM range, whereas that of cysteine is much lower (10-20 µM; ref. 50), reflecting the dynamic balance between its generation from the cells and its extracellular oxidation. Interestingly, 10 µM of cysteine could enhance CLL viability without drug treatment (Fig. 4b ). This may explain why CLL cells have a relatively long survival time in the blood circulation. Higher concentrations of cysteine (20-200 µM) showed further protection of CLL cells and promoted drug resistance (Fig. 4b) . Although stromal cells did not enhance the expression of Xc-in CLL cells to promote cystine uptake, they constantly converted cystine to cysteine for CLL cells. Thus, when CLL cells are in close proximity to the bone marrow stromal cells in vivo, the high local concentrations of cysteine near the stromal cells may provide strong protection to the leukaemia cells and promote drug resistance.
One prominent biochemical feature of CLL cells is their high level of ROS generation and oxidative stress 20, 23, 25 . Such intrinsic ROS stress renders them more dependent on the redox regulatory systems to maintain the redox balance. GSH is the most abundant antioxidant in cells to maintain the redox balance and significantly affect cell survival 51 . GSH also inhibits apoptosis through mechanisms not directly involving modulation of ROS (ref. 52 ). Glutathionylation of the anti-apoptotic protein MCL-1 prevents its cleavage by caspase-3 and thus promotes CLL cell survival 23 . A recent study indicated that GSH may promote lymphoid cell survival through maintaining cellular ionic homeostasis 53 . With its nucleophilic property, GSH may conjugate with electrophilic drugs, promote their export and thus decrease the efficacy of anticancer agents 54 . GSH can also reduce the activity of oxaliplatin by decreasing the level of ROS stress induced by the drug 55 . As CLL cells highly rely on stromal cells to provide cysteine for GSH synthesis, this intercellular metabolic pathway may represent a potentially important target for effective killing of CLL cells in vivo. Indeed, our results from the proof-of-principle study using (S)-4-CPG or SSZ to interrupt the cystine → cysteine → GSH flow or using PEITC to directly deplete GSH indicate that such a therapeutic approach is effective in abrogating the stromal protection on CLL cells and enhancing their drug sensitivity. Further evaluation of this biochemical intervention strategy in preclinical and clinical settings is important for the development of effective therapy to overcome drug resistance in vivo. It is possible, however, that stromal cells may protect CLL cells by additional mechanisms such as secretion of cytokines and other stromal factors that promote cell-cell interactions and activate survival signals [8] [9] [10] [11] [12] [13] [14] [15] [16] . The possibility of stromal cells enhancing other antioxidant systems such as thioredoxins, 
Figure 7
Effect of abolishing GSH protection on CLL cells by blocking cystine uptake by stromal cells in vivo. (a) Effect of SSZ on CLL cellular GSH in vivo. CLL cells were obtained by peritoneal washing from Tcl-1 transgenic mice that had developed CLL disease with leukaemia cells in the peritoneal cavity. After a 7-day recovery period, the mice were treated with SSZ (8 mg per mouse, intraperitoneally (i.p.), every 12 h × 3 injections). A second sample of peritoneal CLL cells was obtained 12 h after the last SSZ treatment. GSH was measured as described in the Methods (mean ± s.d.; n = 3; * * P < 0.01). (b) Effect of SSZ on GSH in CLL cells cultured in vitro without stromal cells. Primary CLL cells were cultured overnight to remove stromal cells attaching to the flask surface. CLL cells in suspension were transferred to fresh flasks and incubated with or without SSZ (100-300 µM, 24 h). GSH was measured in triplicate Cell viability was analysed before and after the cells were incubated ex vivo with F-ara-A or oxaliplatin as indicated. (B) The same mouse was allowed a 7-day recovery period and then treated with SSZ (8 mg kg −1 , i.p., three times per week, Monday/Wednesday/Friday). At 24 h after the last drug treatment, CLL cells were isolated and cell viability was analysed before and after the cells were incubated ex vivo with F-ara-A or oxaliplatin as indicated. (C) The experimental conditions were the same as in B, except that the CLL cells were co-cultured with bone marrow stromal cells (StromaNKtert).
superoxide dismutases and catalase in CLL cells should also be considered in developing redox-modulating therapeutic strategies.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) as described previously 26 . Primary CLL cells were obtained from the peripheral blood samples of B-CLL patients, who were diagnosed according to National Cancer Institute criteria 1 . Before blood sample collection, informed consents under a research protocol approved by the Institutional Review Board of MD Anderson Cancer Center were obtained from all patients in accordance with the Declaration of Helsinki. In all experiments, CLL cells were isolated from blood samples by density gradient centrifugation 59 and incubated in RPMI 1640 medium containing 10% FBS and penicillin (100 U ml −1 ) + streptomycin (100 µg ml −1 ) overnight before experiments.
Cell viability assays.
To determine the effect of bone marrow stromal cells and conditioned medium on CLL cells against drug-and stress-induced apoptosis, HS5 (5 × 10 4 cells ml −1 ), StromaNKtert (4 × 10 4 cells ml −1 ) and KUSA-H1 (1 × 10 4 cells ml −1 ) were seeded in 24-well plates and allowed to adhere and grow overnight before the addition of CLL cells. The stromal-conditioned medium was prepared from HS5 cells culture (in RPMI 1640 + 10% FBS for 5 days), clarified by centrifugation and used immediately. CLL cells were isolated from blood samples, incubated overnight and then transferred to 24-well plates with or without pre-seeded stromal cells or stromal-conditioned medium. For co-culture in a Transwell system (Corning Incorporated), CLL cells were seeded in the top chambers, which were inserted into the bottom wells with pre-seeded stromal cells. After co-culture for 1 day, CLL cells were then treated with various compounds (F-ara-A, oxaliplatin, PEITC and H 2 O 2 ) under the conditions indicated in the figure legends. To block cystine uptake by the stromal cells, S-4-CPG (Tocris Bioscience) was added at the beginning of the stromal cell seeding. Cell viability was determined by flow cytometry after double staining with annexin-V (BD Biosciences) and PI as described previously 60 . All assays were repeated at least three times using primary CLL cells from different patient samples.
Analysis of GSH in cell extracts and in culture medium. GSH was measured
using an assay kit from Cayman Chemical, based on the enzymatic recycling catalysed by glutathione reductase and the reaction of GSH with 5,5 -dithio-bis-2nitrobenzoic acid (DTNB) to produce a yellow product, which was quantified by a spectrometer. After CLL cells were cultured under various experimental conditions, they were collected, sonicated and deproteinated by precipitation with an equal volume of 10% metaphosphoric acid (Sigma-Aldrich). The precipitated proteins were removed by centrifugation at 3,000g for 5 min. The supernatant was collected, neutralized and assayed for GSH and GSSG using the Cayman glutathione assay kit according to the procedures recommended by the manufacturer. The culture medium was cleared by centrifugation, deproteinated by metaphosphoric acid and subjected to the same GSH assay. GSH concentrations were calculated using the standard curve generated in parallel experiments. To minimize the influence of other thiols in the medium, both the end-point method and kinetic methods were used for analysis. For the end-point method, the GSH concentration was calculated from the reading of a 25-min reaction. For the kinetic method, the slopes of the absorbance changes (405 nm) were obtained for a range of standard GSH concentrations to generate a standard curve (slopes versus concentrations). The GSH concentrations in the investigated samples were calculated from their respective slopes in reference to the standard curve. Data were obtained from triplicate measurements.
Analysis of cysteine by LC-MS/MS. Cysteine in stromal-conditioned medium
was analysed by LC-MS/MS using a triple-quadrupole mass spectrometer (Agilent 6460). Chromatography was carried out on a Zorbax SB-C18 rapid-resolution high-definition column (3.0 × 100 mm, 1.8 µm particle size; Agilent). Buffer A contained 0.5% formic acid and 0.3% heptafluorobutyric acid in HPLC-grade water (Burdick and Jackson); buffer B contained 0.5% formic acid and 0.3% heptafluorobutyric acid in HPLC-grade acetonitrile (Honey Burdick and Jackson). The separation was conducted at 0.4 ml min −1 with an initial hold for 1 min (elapsed time) at 2% B, followed by a linear gradient to 40% B for 5 min, a ramp (0.1 min) to 90% B and hold for 1 min, followed by a return ramp to 2% B, and stopped at 8 min. This gradient was used for both quantitative runs and the full-scan tandem mass spectrometry confirmation of identity analysis. Under these conditions, cysteine eluted at 3.3 min and cystine eluted at 4.2 min. Samples were diluted 10-fold with buffer A before injection. For confirmation of chemical identity, the singly charged, protonated cysteine ion (MH + ) was selected for fragmentation, using the standard solution of 1 µM cysteine. The full-scan fragment spectra were collected at a fragmentor voltage of 72 and collision energy of 15. The following transitions and conditions were used for cysteine: 122 → 59, CE 22, Frag 72; 122 → 76 (qualifier), CE 10, Frag 72. For quantification, the standard curve obtained from 0.1 µM to 10 µM authentic cysteine was used to calculate the concentrations of cysteine in the test samples, which were analysed in triplicate.
Flow cytometric analysis of cellular ROS and thiol contents. Cellular ROS levels were quantified by flow cytometry analysis as described previously 23 . CLL cells (1 × 10 6 cells ml −1 ) were transferred to a 24-well plate and incubated with 1 µM CM-H 2 DCF-DA (Invitrogen) in regular culture medium for 60 min at 37 • C in the dark. Stained cells were rinsed twice with PBS and analysed immediately by flow cytometry using a FACSCalibur equipped with CellQuest Pro software. To determine cellular thiol contents, CLL cells (1 × 10 6 cells ml −1 ) were collected and washed in PBS and stained with 0.5 µM CMFDA (Invitrogen) in PBS for 15 min at room temperature in the dark, followed by flow cytometry analysis. ROS levels in viable cells were determined by chemical probe (CM-H 2 DCF-DA for cellular ROS), using FSC/SSC gating to differentiate dead and viable cells as described previously 61, 62 .
Separation of stromal-conditioned medium into HMW and LMW components. HS5 stromal cells were cultured in RPMI 1640 medium with 10% FBS until 80% confluence. The cells were washed twice with serum-free RPMI 1640, and then cultured in serum-free medium for 3 days. The conditioned medium was collected, cleared by centrifugation and then loaded to the reservoir chamber of the Amicon Ultra-15 centrifugal filter unit with a molecular weight cutoff of M r 3K (Millipore). The tube was centrifuged at 4,000g at 4 • C for 15 min. The concentrated liquid remaining in the upper reservoir (HMW fraction) was collected and reconstituted with serum-free medium to the same volume as before centrifugation. The components that passed the filter were collected as the LMW fraction. Both fractions were used immediately after preparation.
Western blot analysis. Cell lysates were prepared and equal amounts of protein were electrophoresed on SDS-PAGE gels using standard conditions. The proteins were transferred to nitrocellulose membranes, which were probed with the following antibodies: GCLC (Santa Cruz Biotechnology); xCT (Novus Biologicals); β-actin (Sigma-Aldrich). The antibody dilution for detection of GCLC, xCT and β-actin was 1:1,000, 1:2,500 and 1:20,000, respectively. Protein bands were visualized by chemiluminescent detection.
Assessment of requirements for exogenous cystine in CLL culture. Bone
marrow stromal cells (HS5) were plated and allowed to adhere overnight as indicated in the figure legends. CLL cells were isolated from blood samples and incubated overnight. The culture medium of both cells was removed, followed by a rinse with warm PBS. CLL cells were then resuspended in cystine-free RPMI 1,640 (Mediatech) supplemented with 10% dialysed FBS (Thermo Scientific HyClone) and added to the culture dish containing pre-washed HS5 stromal cells. Various concentrations of cystine (5-200 µM), 2-ME (20 µM) or their combination were added to the culture as indicated in the figure legends. GSH and cell viability were measured as described above.
Assessment of cystine and cysteine uptake.
To measure cystine uptake, CLL and HS5 cells alone or in co-culture were incubated in fresh cystine-free RPMI 1640 supplemented with dialysed 10% FBS. [ 14 C]cystine (PerkinElmer) was added (0.2 µCi ml −1 ) and incubated for 4-6 h as indicated. The cells were washed twice with cold PBS. Cell pellets were resuspended in 200 µL PBS, lysed with 3 ml scintillation fluid and radioactivity was measured by a Beckman liquid scintillation counter. To measure cysteine uptake, [ 14 C]cysteine was generated by reduction of [ 14 C]cystine using 5 mM 2-ME (37 • C, 15 min) in a test tube, and then added to the cell culture. [ 14 C]cysteine uptake was measured in the same way as described above. All experiments were carried out in triplicate.
Statistical analyses.
All experiments were done in CLL cells from at least three different patient samples, and with stromal cells from three separate culture flasks. Statistical significance was analysed by Student's t -test, and P values of < 0.05 were considered statistically significant. Histograms and plots were generated using the Prizm software (GraphPad). 
